Related Experiment Videos
Sialadenosis in bulimia. A new treatment
1Department of Internal Medicine, Columbine Hospital, Littleton, CO 80126.
Archives of Otolaryngology--Head & Neck Surgery
|July 1, 1993
Abstract
Objective:
To see whether a cholinomimetic medication would help resolve the parotid gland enlargement associated with self-induced vomiting in bulimic patients.
Setting/Design:
The medication was administered on an inpatient eating disorder unit to bulimic patients with refractory sialadenosis.
Intervention:
Pilocarpine hydrochloride drops were administered orally at a dosage of 1.25 to 5.0 mg/d until the parotid gland enlargement was significantly reduced.
Results:
There was a marked diminution in the size of the parotid gland enlargement.
Conclusion:
Pilocarpine has proved to be beneficial in the treatment of sialadenosis in bulimic patients.